MétaCan
← all works

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

2017· article· en· 483 citations· W2621105275 on OpenAlex· 10.1016/j.neuroimage.2017.05.058

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.071
GPT teacher head0.393
Teacher spread
0.322 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
NeuroImage
Topic
Dementia and Cognitive Impairment Research
Field
Medicine
Canadian institutions
Funders
National Institute on AgingNational Institute of Biomedical Imaging and BioengineeringCanadian Institutes of Health ResearchAvid RadiopharmaceuticalsUniversity of California, San DiegoGenentechNational Institutes of HealthTakeda Pharmaceutical CompanyIXICOH. Lundbeck A/SServierEisaiNorthern California Institute for Research and EducationPfizerBiogenBioClinicaAbbVieRocheUniversity of Southern CaliforniaNovartis Pharmaceuticals CorporationU.S. Department of DefenseEli Lilly and CompanyTau ConsortiumBristol-Myers SquibbAlzheimer's Drug Discovery FoundationMerckFujirebio EuropeAlzheimer's AssociationFoundation for the National Institutes of HealthGE HealthcareAlzheimer's Disease Neuroimaging Initiative
Keywords
Positron emission tomographyBiomarkerPet imagingDiseaseMedicineNeuroimagingAlzheimer's diseaseNeuroscienceAmyloid (mycology)PsychologyPathologyBiology
Has abstract in OpenAlex
no